This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by KLYSNER, R.
Right arrow Articles by PETERSEN, H. E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KLYSNER, R.
Right arrow Articles by PETERSEN, H. E. H.
The British Journal of Psychiatry (2002) 181: 29-35
© 2002 The Royal College of Psychiatrists

Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy

RENÉ KLYSNER, MD, JESPER BENT-HANSEN, MD, HANNE L. HANSEN, MD, MARIANNE LUNDE, ELISABETH PLEIDRUP, MD and DORTE LOLDRUP POULSEN, MD

Psychiatric Research Clinic, Frederiksberg Hospital, Denmark

MARC ANDERSEN, PhD and HANS ERIK HØPFNER PETERSEN, MSc

International Clinical Research, H. Lundbeck A/S, Denmark

Correspondence: Marc Andersen, Biostatistics Department, International Clinical Research, H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby, Denmark. Tel: +45 36 30 1311, ext. 2302; fax: +45 36 44 0787; e-mail: ma{at}lundbeck.com

Declaration of interest Funded by H. Lundbeck A/S.

Background The highly recurrent nature of major depression in the young and the elderly warrants long-term antidepressant treatment.

Aims To compare the prophylactic efficacy of citalopram and placebo in elderly patients; to evaluate long-term tolerability of citalopram.

Method Out-patients, >=65 years, with unipolar major depression (DSM—IV: 296.2 x or 296.3 x) and Montgomery—Åsberg Depression Rating Scale score >=22 were treated with citalopram 20-40 mg for 8 weeks. Responders continued on their final fixed dose of citalopram for 16 weeks before randomisation to double-blind treatment with citalopram or placebo for at least 48 weeks.

Results Nineteen of the 60 patients using citalopram v. 41 of the 61 patients using placebo had recurrence. Time to recurrence was significantly different between citalopram- and placebo-patients, in favour of citalopram (log-rank test, P<0.0001). Long-term treatment was well tolerated.

Conclusions Long-term treatment with citalopram is effective in preventing recurrence of depression in the elderly and is well tolerated.




This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
G. Gartlehner, B. N. Gaynes, R. A. Hansen, P. Thieda, A. DeVeaugh-Geiss, E. E. Krebs, C. G. Moore, L. Morgan, and K. N. Lohr
Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians
Ann Intern Med, November 18, 2008; 149(10): 734 - 750.
[Abstract] [Full Text] [PDF]

Home page
 Psychiatr. Serv.Home page
R. Hansen, B. Gaynes, P. Thieda, G. Gartlehner, A. Deveaugh-Geiss, E. Krebs, and K. Lohr
Meta-analysis of Major Depressive Disorder Relapse and Recurrence With Second-Generation Antidepressants
Psychiatr Serv, October 1, 2008; 59(10): 1121 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. Unutzer
Late-Life Depression
N. Engl. J. Med., November 29, 2007; 357(22): 2269 - 2276.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
M. M. Williams, R. E. Clouse, B. D. Nix, E. H. Rubin, G. S. Sayuk, J. B. McGill, A. J. Gelenberg, P. S. Ciechanowski, I. B. Hirsch, and P. J. Lustman
Efficacy of Sertraline in Prevention of Depression Recurrence in Older Versus Younger Adults With Diabetes
Diabetes Care, April 1, 2007; 30(4): 801 - 806.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
C. E Wills
Maintenance treatment with paroxetine, but not psychotherapy, prevented recurrent major depression in older people
Evid. Based Nurs., October 1, 2006; 9(4): 119 - 119.
[Full Text] [PDF]

Home page
 J Clin PharmacolHome page
F. E. Lotrich and B. G. Pollock
Aging and Clinical Pharmacology: Implications for Antidepressants
J. Clin. Pharmacol., October 1, 2005; 45(10): 1106 - 1122.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
L. J. Fochtmann and A. J. Gelenberg
Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition
Focus, January 1, 2005; 3(1): 34 - 42.
[Full Text] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
R. Baldwin and R. Wild
Management of depression in later life
Adv. Psychiatr. Treat., March 1, 2004; 10(2): 131 - 139.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
S. Kumar and K. C. M. Wilson
Prophylaxis of depression in older people * Author's reply
The British Journal of Psychiatry, October 1, 2003; 183(4): 365 - 365.
[Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
K. C. M. WILSON, P. G. MOTTRAM, L. ASHWORTH, and M. T. ABOU-SALEH
Older community residents with depression: long-term treatment with sertraline: Randomised, double-blind, placebo-controlled study
The British Journal of Psychiatry, June 1, 2003; 182(6): 492 - 497.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Med.Home page
ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
Evid. Based Med., March 1, 2003; 8(2): 35 - 35.
[Full Text] [PDF]

Home page
 Evid. Based Ment. HealthHome page
B. Appelberg
Long term citalopram prevents recurrent depression in the elderly and is well tolerated
Evid. Based Ment. Health, February 1, 2003; 6(1): 24 - 24.
[Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
A. K. Jainer, N. Soni, R. Klysner, and M. Andersen
Unethical use of placebo controls * Authors' reply
The British Journal of Psychiatry, December 1, 2002; 181 (6): 532 - 533.
[Full Text]